Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Nov 20 2019

Full Issue

History Repeating Itself? Sackler-Owned Drug Company Tell Doctors In China That OxyContin Is Less Addictive.

The Associated Press investigated the marketing techniques of Mundipharma, the Sacklers’ Chinese affiliate, and found that the tactics the company is using mirror ones used by Purdue Pharma at the beginning of the U.S. opioid epidemic. Meanwhile, the judge overseeing the consolidated opioid case set a trial date for the lawsuit against major pharmacy chains. Other news on the national drug crisis comes out of Florida, as well.

The Associated Press: Oxy Sales In China Driven By Misleading Addiction Claims

Thousands of lawsuits across the United States have accused a drug company owned by the billionaire Sackler family of using false claims to push highly addictive opioids on an unsuspecting nation, fueling the deadliest drug epidemic in U.S. history. Yet, even as its U.S. drugmaker collapses under the charges, another company owned by the family has used the same tactics to peddle its signature painkiller, OxyContin, in China, according to interviews with current and former employees and documents obtained by the Associated Press. (Kinetz, 11/20)

The Wall Street Journal: States AGs Agree To Longer Halt On Purdue Family Claims

Purdue Pharma LP has convinced 24 states and the District of Columbia to comply with a bankruptcy court injunction halting opioid lawsuits against the company and the controlling Sackler family at least temporarily, Purdue’s lawyer said at a bankruptcy hearing. Last month, the judge presiding over Purdue’s bankruptcy enjoined lawsuits against the maker of the opioid OxyContin and the Sacklers. Roughly half of all state attorneys general and the District of Columbia had argued against the injunction, which extends until April 8. (Biswas, 11/19)

The Washington Post: Pharmacy Chains Face October 2020 Trial Over Their Role In The Opioid Crisis

Seeking to kick-start the sprawling nationwide opioid litigation, a federal judge on Tuesday scheduled a trial against major pharmacy chains for next October and proposed sending three other cases back to other federal courts where they originated. Judge Dan Aaron Polster, the Ohio federal judge in charge of the nearly 2,500 lawsuits filed against the drug industry in federal courts across the country, said he would preside over a case that pits two Ohio counties, Summit and Cuyahoga, against some of the nation’s largest pharmacy chains. (Bernstein, 11/19)

Miami Herald: Miami-Dade Opioid-Related Deaths Fell By Nearly 100 In 2018

Since 2016, public health advocates in Miami-Dade County have led the state in confronting Florida’s opioid epidemic by starting a needle exchange that also widely distributed naloxone, a drug that counters overdoses, and getting it onto the streets. With the latest data, experts believe those efforts have saved nearly 100 lives in 2018 alone. (Conark, 11/19)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF